Dr. Francis Lee is an accomplished neurobiologist and psychiatrist studying the molecular basis of mood and anxiety disorders, with the goal of understanding why many of them emerge during the transition from childhood to adolescence. By combining basic and translational approaches, Dr. Lee’s discoveries have led to the development of advanced biologically targeted psychiatric diagnostic […]
Nancy A. Thornberry has decades of experience in the pharmaceutical and biotech industries, with responsibilities spanning research and development, business development, customer engagement, and strategy. From 2015-2021, she was CEO of Kallyope, a NYC-based biotechnology company focused on the discovery and development of novel therapeutic agents targeting the gut and gut-brain axis. She remains on […]
Selwyn M. Vickers, MD, FACS, is the President and CEO of Memorial Sloan Kettering Cancer Center. He assumed the role on September 19, 2022. Vickers is an internationally recognized pancreatic cancer surgeon, pancreatic cancer researcher, and pioneer in health disparities research. He is a member of the National Academy of Medicine and the Johns Hopkins […]
Katrina Armstrong, MD, leads Columbia University’s medical campus as the Chief Executive Officer of CUIMC, which includes the Vagelos College of Physicians and Surgeons (VP&S), the School of Nursing, the College of Dental Medicine, and the Mailman School of Public Health. She also is Executive Vice President for Health and Biomedical Sciences for Columbia University […]
John P. Havens is a former business executive and recognized leader in the financial services industry. Prior to his retirement in 2019, Mr. Havens served as Partner and Non-Executive Chairman at Napier Park Capital, an alternative asset management firm originally spun out of Citigroup. During his time at Napier, assets grew from $5.5 billion to […]
Joseph E. Edelman is the Founder, Chief Executive Officer and Portfolio Manager of Perceptive Advisors, LLC, a hedge fund focused on investment opportunities in health care with an emphasis on biotechnology. Prior to founding Perceptive Advisors in 1999, he was the Senior Analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund. Previously, […]
